Araris Biotech AG Revenue and Competitors
Estimated Revenue & Valuation
- Araris Biotech AG's estimated annual revenue is currently $5.3M per year.
- Araris Biotech AG's estimated revenue per employee is $155,000
- Araris Biotech AG's total funding is $44M.
Employee Data
- Araris Biotech AG has 34 Employees.
- Araris Biotech AG grew their employee count by 6% last year.
Araris Biotech AG's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
Araris Biotech AG Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Araris Biotech AG?
Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf' antibodies without the need of prior antibody engineering.
keywords:N/A
$44M
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Araris Biotech AG News
2022-04-06 - Araris Biotech AG Presents Preclinical Data Highlighting Anti ...
ZURICH, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) -- Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate...
2022-03-30 - Araris Biotech AG to Present at 12th Annual World ADC ...
Araris Biotech AG is pioneering the development of its novel antibody-drug conjugate (ADC)-linker technology to enable efficient and precise...
Other Companies in Zurich
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.9M | 34 | -19% | N/A |
#2 | $6M | 34 | 17% | N/A |
#3 | $4.1M | 35 | -5% | N/A |
#4 | $10.8M | 35 | 40% | N/A |
#5 | $3.6M | 35 | 13% | N/A |